Cited by 458

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Perfluorooctane Sulfonate (PFOS) and Related Perfluorinated Compounds in Human Maternal and Cord Blood Samples: Assessment of PFOS Exposure in a Susceptible Population during Pregnancy

Open access

Inoue, Koichi, Okada, Fumio, Ito, Rie, Kato, Shizue, Sasaki, Seiko, Nakajima, Sonomi, Uno, Akiko, Saijo, Yasuaki, Sata, Fumihiro, Yoshimura, Yoshihiro, Kishi, Reiko, Nakazawa, Hiroyuki·2004·Environmental Health Perspectives

DOI 10.1289/ehp.6864

Open this paper in CoChat — free account

Abstract

Fluorinated organic compounds (FOCs), such as perfluorooctane sulfonate (PFOS), perfluoro-octanoate (PFOA), and perfluorooctane sulfonylamide (PFOSA), are widely used in the manufacture of plastic, electronics, textile, and construction material in the apparel, leather, and upholstery industries. FOCs have been detected in human blood samples. Studies have indicated that FOCs may be detrimental to rodent development possibly by affecting thyroid hormone levels. In the present study, we determined the concentrations of FOCs in maternal and cord blood samples. Pregnant women 17-37 years of age were enrolled as subjects. FOCs in 15 pairs of maternal and cord blood samples were analyzed by liquid chromatography-electrospray mass spectrometry coupled with online extraction. The limits of quantification of PFOS, PFOA, and PFOSA in human plasma or serum were 0.5, 0.5, and 1.0 ng/mL, respectively. The method enables the precise determination of FOCs and can be applied to the detection of FOCs in human blood samples for monitoring human exposure. PFOS concentrations in maternal samples ranged from 4.9 to 17.6 ng/mL, whereas those in fetal samples ranged from 1.6 to 5.3 ng/mL. In contrast, PFOSA was not detected in fetal or maternal samples, whereas PFOA was detected only in maternal samples (range, < 0.5 to 2.3 ng/mL, 4 of 15). Our results revealed a high correlation between PFOS concentrations in maternal and cord blood (r2 = 0.876). However, we did not find any significant correlations between PFOS concentration in maternal and cord blood samples and age bracket, birth weight, or levels of thyroid-stimulating hormone or free thyroxine. Our study revealed that human fetuses in Japan may be exposed to relatively high levels of FOCs. Further investigation is required to determine the postnatal effects of fetal exposure to FOCs. Key words: cord blood, fluorinated organic compounds, human, PFOA, PFOS, PFOSA, pregnancy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1289/ehp.6864

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Global Distribution of Perfluorooctane Sulfonate in Wildlife
Giesy, J. P., & Kannan, K. (2001) · Environmental Science & Technology · doi:10.1021/es001834k · Cited by 2,750
Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices
Hansen, K. J., Clemen, L. A., Ellefson, M. E., & Johnson, H. O. (2001) · Environmental Science & Technology · doi:10.1021/es001489z · Cited by 923
Subchronic Toxicity Studies on Perfluorooctanesulfonate Potassium Salt in Cynomolgus Monkeys
Seacat, A. M. (2002) · Toxicological Sciences · doi:10.1093/toxsci/68.1.249 · Cited by 564 · cited 2×
“In addition, PFOS is well absorbed but poorly metabolized and excreted, and it has a long half-life (200 days) in monkeys (Seacat et al. 2002).”
Background
Exposure to Perfluorooctane Sulfonate during Pregnancy in Rat and Mouse. I: Maternal and Prenatal Evaluations
Thibodeaux, J. R., Hanson, R. G., Rogers, J. M., Grey, B. E., Barbee, B. D., Richards, J. H., Butenhoff, J. L., Stevenson, L. A., & Lau, C. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg121 · Cited by 445

Show all 4 references

Research works printed but not linked: 27

10.1289/ehp.6128 · DOI · Paper page
10.1007/s00244-002-2102-6 · DOI
Calafat AM, 2003, Quantitative analysis of serum and breast milk for perfluorochemical surfactants, Organohalogen Compounds, 62, 319
10.1016/S0048-9697(02)00167-5 · DOI
10.1038/sj.jea.7500090 · DOI
10.1021/tx034005w · DOI · Paper page
10.1016/S1532-0456(03)00043-7 · DOI · Paper page
10.1093/toxsci/68.2.429 · DOI
10.1016/S0045-6535(02)00304-1 · DOI
10.1021/es001873w · DOI · Paper page
10.1021/es0205028 · DOI
10.1021/es961007c · DOI · Paper page
10.1093/toxsci/kfg122 · DOI · Paper page
10.1016/S0300-483X(02)00081-1 · DOI · Paper page
10.1289/ehp.6146 · DOI · Paper page
Okada F Ito R Inoue K Nakazawa N 2003. Fluorinated organic compounds exposure in residents of Japan: development of liquid chromatography–mass spectrometry coupled with on-line extraction for determination of PFOS PFOA and PFOSA in blood samples [Abstract]. In: Proceedings of the 6th annual meeting of Japan Society of Endocrine Disrupters Research 2–3 December 2003. Tsukuba Ibaragi Japan:Japan Society of Endocrine Disrupters Research 66.
10.1097/01.jom.0000052958.59271.10 · DOI · Paper page
10.1021/es020955c · DOI
10.1080/15428110308984859 · DOI
10.1021/es012317k · DOI · Paper page
10.1021/es032467q · DOI
10.1007/s00244-003-0163-9 · DOI
10.1016/S0045-6535(00)00450-1 · DOI
10.1016/S0300-483X(02)00511-5 · DOI · Paper page
10.1021/es0303440 · DOI · Paper page
U.S. EPA, 2000, Perfluorooctyl Sufonates: Proposed Significant New Use Rule, Fed Reg, 65, 62319
10.1590/S0036-36342000000500003 · DOI

Perfluoroalkyl Acids: A Review of Monitoring and Toxicological Findings
Lau, C., Anitole, K., Hodes, C., Lai, D., Pfahles-Hutchens, A., & Seed, J. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm128 · Cited by 2,620
Risk to human health related to the presence of perfluoroalkyl substances in food
Panel), E. P. O. C. I. T. F. C. (. C., Schrenk, D., Bignami, M., Bodin, L., Chipman, J. K., del Mazo, J., Grasl‐Kraupp, B., Hogstrand, C., Hoogenboom, L. (., Leblanc, J., et al. (2020) · EFSA Journal · doi:10.2903/j.efsa.2020.6223 · Cited by 989
Accumulation of perfluorinated alkyl substances (PFAS) in agricultural plants: A review
Ghisi, R., Vamerali, T., & Manzetti, S. (2019) · Environmental Research · doi:10.1016/j.envres.2018.10.023 · Cited by 705
Epidemiologic Evidence on the Health Effects of Perfluorooctanoic Acid (PFOA)
Steenland, K., Fletcher, T., & Savitz, D. A. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.0901827 · Cited by 660
Perfluoroalkyl and polyfluoroalkyl substances in consumer products
Kotthoff, M., Müller, J., Jürling, H., Schlummer, M., & Fiedler, D. (2015) · Environmental Science and Pollution Research · doi:10.1007/s11356-015-4202-7 · Cited by 613
Association between Serum Perfluorooctanoic Acid (PFOA) and Thyroid Disease in the U.S. National Health and Nutrition Examination Survey
Melzer, D., Rice, N., Depledge, M. H., Henley, W. E., & Galloway, T. S. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.0901584 · Cited by 496
Toxicology of perfluorinated compounds
Stahl, T., Mattern, D., & Brunn, H. (2011) · Environmental Sciences Europe · doi:10.1186/2190-4715-23-38 · Cited by 432
Characterisation of human exposure pathways to perfluorinated compounds — Comparing exposure estimates with biomarkers of exposure
Haug, L. S., Huber, S., Becher, G., & Thomsen, C. (2011) · Environment International · doi:10.1016/j.envint.2011.01.011 · Cited by 391
Phenotypic Dichotomy Following Developmental Exposure to Perfluorooctanoic Acid (PFOA) in Female CD-1 Mice: Low Doses Induce Elevated Serum Leptin and Insulin, and Overweight in Mid-life☆☆
Hines, E. P., White, S. S., Stanko, J. P., Gibbs-Flournoy, E. A., Lau, C., & Fenton, S. E. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.02.021 · Cited by 282
Perfluorooctanoic Acid, Perfluorooctanesulfonate, and Serum Lipids in Children and Adolescents: Results From the C8 Health Project
Frisbee, S. J., Shankar, A., Knox, S. S., Steenland, K., Savitz, D. A., Fletcher, T., & Ducatman, A. M. (2010) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2010.163 · Cited by 274
Per- and polyfluoroalkyl substances in human serum and urine samples from a residentially exposed community
Worley, R. R., Moore, S. M., Tierney, B. C., Ye, X., Calafat, A. M., Campbell, S., Woudneh, M. B., & Fisher, J. (2017) · Environment International · doi:10.1016/j.envint.2017.06.007 · Cited by 272
Distribution and effects of branched versus linear isomers of PFOA, PFOS, and PFHxS: A review of recent literature
Schulz, K., Silva, M. R., & Klaper, R. (2020) · Science of The Total Environment · doi:10.1016/j.scitotenv.2020.139186 · Cited by 259
Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study
Midasch, O., Drexler, H., Hart, N., Beckmann, M. W., & Angerer, J. (2007) · International Archives of Occupational and Environmental Health · doi:10.1007/s00420-006-0165-9 · Cited by 245
Exposure to perfluoroalkyl substances and thyroid function in pregnant women and children: a systematic review of epidemiologic studies
Ballesteros, V., Costa, O., Iñiguez, C., Fletcher, T., Ballester, F., & Lopez-Espinosa, M.-J. (2017) · Environment International · doi:10.1016/j.envint.2016.10.015 · Cited by 242
Isomer-Specific Binding Affinity of Perfluorooctanesulfonate (PFOS) and Perfluorooctanoate (PFOA) to Serum Proteins
Beesoon, S., & Martin, J. W. (2015) · Environmental Science & Technology · doi:10.1021/es505399w · Cited by 223
Interspecies differences in perfluoroalkyl substances (PFAS) toxicokinetics and application to health-based criteria
Pizzurro, D. M., Seeley, M., Kerper, L. E., & Beck, B. D. (2019) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2019.05.008 · Cited by 206
Maternal exposure to perfluorinated acids and fetal growth
Hamm, M. P., Cherry, N. M., Chan, E., Martin, J. W., & Burstyn, I. (2010) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/jes.2009.57 · Cited by 151
Associations between Perfluoroalkyl acids (PFASs) and maternal thyroid hormones in early pregnancy: A population-based cohort study
Webster, G. M., Venners, S. A., Mattman, A., & Martin, J. W. (2014) · Environmental Research · doi:10.1016/j.envres.2014.06.012 · Cited by 145
Early life exposure to per- and polyfluoroalkyl substances (PFASs): a critical review
Winkens, K., Vestergren, R., Berger, U., & Cousins, I. T. (2017) · Emerging Contaminants · doi:10.1016/j.emcon.2017.05.001 · Cited by 145
Development of PBPK models for PFOA and PFOS for human pregnancy and lactation life stages
Loccisano, A. E., Longnecker, M. P., Campbell, J. L., Andersen, M. E., & Clewell, H. J. (2013) · Journal of Toxicology and Environmental Health, Part A · doi:10.1080/15287394.2012.722523 · Cited by 141
Transfer of perfluoroalkyl substances from mother to fetus in a Spanish birth cohort
Manzano-Salgado, C. B., Casas, M., Lopez-Espinosa, M.-J., Ballester, F., Basterrechea, M., Grimalt, J. O., Jiménez, A.-M., Kraus, T., Schettgen, T., Sunyer, J., et al. (2015) · Environmental Research · doi:10.1016/j.envres.2015.07.020 · Cited by 139
Prenatal exposure to perfluoroalkyl substances and birth outcomes in a Spanish birth cohort
Manzano-Salgado, C. B., Casas, M., Lopez-Espinosa, M.-J., Ballester, F., Iñiguez, C., Martinez, D., Costa, O., Santa-Marina, L., Pereda-Pereda, E., Schettgen, T., et al. (2017) · Environment International · doi:10.1016/j.envint.2017.09.006 · Cited by 134
Binding of PFOS to Serum Albumin and DNA: Insight into the Molecular Toxicity of Perfluorochemicals
Zhang, X., Chen, L., Fei, X.-C., Ma, Y.-S., & Gao, H.-W. (2009) · BMC Molecular Biology · doi:10.1186/1471-2199-10-16 · Cited by 119
Gestational and Lactational Exposure to Potassium Perfluorooctanesulfonate (K+PFOS) in Rats: Toxicokinetics, Thyroid Hormone Status, and Related Gene Expression
Chang, S.-C., Ehresman, D. J., Bjork, J. A., Wallace, K. B., Parker, G. A., Stump, D. G., & Butenhoff, J. L. (2009) · Reproductive Toxicology · doi:10.1016/j.reprotox.2009.01.005 · Cited by 118
The transplacental transfer efficiency of per- and polyfluoroalkyl substances (PFAS): a first meta-analysis
Appel, M., Forsthuber, M., Ramos, R., Widhalm, R., Granitzer, S., Uhl, M., Hengstschläger, M., Stamm, T., & Gundacker, C. (2022) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937404.2021.2009946 · Cited by 104
Early-life exposure to perfluoroalkyl substances and childhood metabolic function
Fleisch, A. F., Rifas-Shiman, S. L., Mora, A. M., Calafat, A. M., Ye, X., Luttmann-Gibson, H., Gillman, M. W., Oken, E., & Sagiv, S. K. (2017) · Environmental Health Perspectives · doi:10.1289/ehp303 · Cited by 91
Perfluoroalkyl Chemicals in Neurological Health and Disease: Human Concerns and Animal Models
Piekarski, D., Diaz, K., & McNerney, M. (2020) · NeuroToxicology · doi:10.1016/j.neuro.2020.01.001 · Cited by 76
Tissue Distribution of 35S-Labelled Perfluorooctane Sulfonate (PFOS) in C57Bl/6 Mice Following Late Gestational Exposure
Borg, D., Bogdanska, J., Sundström, M., Nobel, S., Håkansson, H., Bergman, Å., DePierre, J. W., Halldin, K., & Bergström, U. (2010) · Reproductive Toxicology · doi:10.1016/j.reprotox.2010.07.004 · Cited by 76
An improved method for the analysis of volatile polyfluorinated alkyl substances in environmental air samples
Jahnke, A., Ahrens, L., Ebinghaus, R., Berger, U., Barber, J. L., & Temme, C. (2007) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-006-1008-y · Cited by 74
Method development for the determination of residual fluorotelomer raw materials and perflurooctanoate in fluorotelomer-based products by gas chromatography and liquid chromatography mass spectrometry
Larsen, B. S., Stchur, P., Szostek, B., Bachmura, S. F., Rowand, R. C., Prickett, K. B., Korzeniowski, S. H., & Buck, R. C. (2006) · Journal of Chromatography A · doi:10.1016/j.chroma.2006.01.086 · Cited by 65
Perfluorooctane sulfonate induces mitochondrial calcium overload and early hepatic insulin resistance via autophagy/detyrosinated alpha-tubulin-regulated IP3R2-VDAC1-MICU1 interaction
Dong, Z., Wang, J., Qiu, T., Wu, J., An, Y., Shi, X., Sun, X., Jiang, L., Liu, X., Yang, G., et al. (2022) · Science of The Total Environment · doi:10.1016/j.scitotenv.2022.153933 · Cited by 41
Perfluorooctane Sulfonate and Perfluorooctanoic Acid in Surgical Thyroid Specimens of Patients with Thyroid Diseases
Pirali, B., Negri, S., Chytiris, S., Perissi, A., Villani, L., La Manna, L., Cottica, D., Ferrari, M., Imbriani, M., Rotondi, M., et al. (2009) · Thyroid · doi:10.1089/thy.2009.0174 · Cited by 38
Prenatal exposure to mixtures of persistent endocrine-disrupting chemicals and birth size in a population-based cohort of British girls
Marks, K. J., Howards, P. P., Smarr, M. M., Flanders, W. D., Northstone, K., Daniel, J. H., Sjödin, A., Calafat, A. M., & Hartman, T. J. (2021) · Epidemiology · doi:10.1097/ede.0000000000001351 · Cited by 30
Time Trends of Perfluoroalkyl Substances in Blood in 30-Year Old Norwegian Men and Women in the Period 1986–2007
Berg, V., Sandanger, T. M., Hanssen, L., Rylander, C., & Nøst, T. H. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-13809-6 · Cited by 29
“As the time trends of PFOS and PFOA in human blood demonstrate sharp declines between 2001 and 2003 (Harada et al. 2005; Harada et al. 2004; Inoue et al. 2004; Olsen et al. 2003; Olsen et al. 2005), childbirth and breastfeeding after this period would result in a more pronounced effect on maternal…”
Background
Estimating the Dynamic Early Life Exposure to PFOA and PFOS of the HELIX Children: Emerging Profiles via Prenatal Exposure, Breastfeeding, and Diet
Ratier, A., Casas, M., Grazuleviciene, R., Slama, R., Småstuen Haug, L., Thomsen, C., Vafeiadi, M., Wright, J., Zeman, F. A., Vrijheid, M., et al. (2024) · Environment International · doi:10.1016/j.envint.2024.108621 · Cited by 16

Authors: Inoue, K., Okada, F., Ito, R., Kato, S., Sasaki, S., Nakajima, S., Uno, A., Saijo, Y., Sata, F., Yoshimura, Y., Kishi, R., & Nakazawa, H.
Venue: Environmental Health Perspectives
Publisher: American Chemical Society (ACS)
Published: 2004-08
Volume: 112
Issue: 11
Pages: 1204-1207
ISSN: 0091-6765 (ISSN-L)
1552-9924
DOI: 10.1289/ehp.6864
OpenAlex: W2144144303
Cited by: 458
References: 4
FWCI: 13.19
Type: journal article
Language: en
Open access: gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

Perfluorooctane Sulfonate (PFOS) and Related Perfluorinated Compounds in Human Maternal and Cord Blood Samples: Assessment of PFOS Exposure in a Susceptible Population during Pregnancy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks

Data sources